GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

VIA Pharmaceuticals VIAP · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2010

Net income

−$9.6m

FY2010FY2010

Free cash flow

−$6.1m

FY2010FY2010

Shareholders' equity

−$18.5m

FY2010FY2010

Income statement

Fiscal years

FY2010
Research and development$1.7m
Operating income−$5.9m
Net income−$9.6m
Diluted earnings per share-0.47

Balance sheet

At each fiscal year end

FY2010
Total assets$499,971
Total liabilities$19.0m
Debt$14.0m
Shareholders' equity−$18.5m
Shares outstanding20m

Cash flow

Fiscal years

FY2010
Cash from operations−$6.1m
Free cash flow−$6.1m

Latest quarters

By quarter end

Dec 2010Sept 2010Jun 2010Mar 2010Dec 2006Sept 2006Jun 2006Mar 2006
Operating income−$885,436−$1.2m−$1.4m−$2.4m−$2.2m−$2.0m−$2.2m−$1.9m
Net income−$2.5m−$2.1m−$2.1m−$2.9m−$2.3m−$2.0m−$2.2m−$2.1m
Diluted earnings per share-0.12-0.10-0.10-0.14-5.21-4.60-5.02-4.93
Cash from operations−$1.0m−$1.0m—−$2.0m————
Total assets$499,971$489,807$376,780$691,542$3.7m$20.1m$23.2m$27.2m
Cash and short-term investments————$3.3m$19.7m$22.8m$26.7m
Debt$14.0m$12.5m$11.3m$10.7m$8.0m——$16.4m
Shareholders' equity−$18.5m−$16.7m−$15.1m−$13.3m−$5.9m$16.2m$18.7m$5.3m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-31.7%-21.4%-3.7%
Net income-24.0%-13.4%-0.0%

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%0%0%10573%80566%1762%33%22731%1796%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 15-to-1 reverse split · 6 Jun 2007

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.